Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
Cell structure for brain damage treatment, production method thereof, and brain damagetreatment agent
Cell structure for brain damage treatment, production method thereof, and brain damagetreatment agent
Authors: Nakamura K.
US 20170095595 A1
US 20170095595 A1
Abstract
An object of the present invention is to provide a cell structure for brain damagetreatment which does not contain glutaraldehyde and in which it is possible to exhibit a sufficient effect of treating brain damage, a production method thereof, and a brain damage treatment agent. According to the present invention, there is provided a cell structure for brain damage treatment which contains biocompatible macromolecular blocks and at least one kind of cell and in which a plurality of the biocompatible macromolecular blocks are disposed in gaps between a plurality of the cells, in which the tap density of the biocompatible macromolecular block is 10 mg/cm3 to 500 mg/cm3 or a value obtained by dividing a square root of a cross-sectional area in a two-dimensional cross-sectional image of the biocompatible macromolecular block by a peripheral length is 0.01 to 0.13.